Mouse models and type 2 diabetes: translational opportunities

Area of Science:

• Endocrinology and Metabolism
• Genetics and Genomics
• Translational Medicine

Background:

• Rising global prevalence of type 2 diabetes (T2D) necessitates improved therapeutic strategies.
• Current treatments often fail to achieve optimal glycaemic control in many patients.
• A deeper understanding of T2D pathogenesis is essential for developing novel interventions.

Purpose of the Study:

• To review the utility of mouse models in T2D research.
• To explore how mouse models can clarify human genome-wide association study (GWAS) findings.
• To identify genes, pathways, and drug targets relevant to T2D.

Main Methods:

• Utilizing genetically modified mouse models to study gene function and disease phenotype.
• Leveraging mouse models for translational research, bridging basic science and public health.
• Analyzing insights gained from mouse models regarding glucose metabolism and insulin secretion.

Main Results:

• Mouse models have provided significant insights into glucose homeostasis and insulin secretion mechanisms.
• These models have confirmed findings from human genome-wide association studies.
• They have facilitated the identification of novel molecular pathways implicated in T2D.

Conclusions:

• Genetically modified mouse models are invaluable tools for advancing T2D research.
• Mouse models accelerate the discovery of preventative measures, diagnostic biomarkers, and therapeutic targets.
• Continued use of mouse models is critical for developing effective T2D therapies and improving public health outcomes.